Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;8(6):1628-1641.
doi: 10.1111/andr.12850. Epub 2020 Jul 12.

Critical evaluation of different available guidelines for late-onset hypogonadism

Vito Angelo Giagulli  1   2 , Marco Castellana  3 , Giuseppe Lisco  4 , Vincenzo Triggiani  1
Affiliations
Free article
Review

Critical evaluation of different available guidelines for late-onset hypogonadism

Vito Angelo Giagulli et al. Andrology. 2020 Nov.
Free article

Abstract

Background: Late-onset hypogonadism (LOH) is a syndrome characterized by clinical and biochemical evidence of low testosterone levels with advancing age. In recent years, several guidelines, position statements and other recommendations have become available. It is unclear whether similar indications are reported in these documents.

Objective: To review similarities and differences among available documents on the management of hypogonadism, with a special focus on LOH.

Materials and methods: PubMed, Google and international societies websites were searched on March 2020 for documents published in the last 10 years on the management of hypogonadism and LOH.

Results: Nine documents were found, each developed by: (a) the American Urological Association; (b) the British Society for Sexual Medicine; (c) the Canadian Medical Association; (d) the Endocrine Society; (e) the Endocrine Society of Australia; (f) the European Academy of Andrology; (g) the European Association of Urology; (h) the International Consultation for Sexual Medicine; and (i) the International Society for the Study of Aging Male.

Discussion: Despite similar principles, differences were found both for the diagnostic workup and follow-up. Particularly, discrepancies were reported both for total and free testosterone levels for diagnosis and for total testosterone for monitoring.

Conclusion: Available documents differ in terms of specific recommendations for the management of hypogonadism and LOH. Given the relevant clinical implications of adequate management of these disorders, future guidelines should report more consistent measures to be adopted in clinical practice.

Keywords: ageing; guidelines; hypogonadism; late-onset hypogonadism; review.

PubMed Disclaimer

References

REFERENCES

    1. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833-876.
    1. Kaufman JM, Lapauw B, Mahmoud A, T'Sjoen G, Huhtaniemi IT. Aging and the Male Reproductive System. Endocr Rev. 2019;40(4):906-972.
    1. Tajar A, Huhtaniemi IT, O'Neill TW, et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2012;97(5):1508-1516.
    1. Barbonetti A, D'Andrea S, Francavilla S. Testosterone replacement therapy. Andrology. 2020 [Epub ahead of print]; https://doi.org/10.1111/andr.12774
    1. Corona G, Torres LO, Maggi M. Testosterone therapy: what we have learned from trials. J Sex Med. 2020;17(3):447-460.

MeSH terms

LinkOut - more resources